Placenta Antibody

Placenta Antibody

Placenta Growth Factor (PGF) Antibody

20-abx001442 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 218.40 EUR
  • 376.80 EUR
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Placenta Growth Factor (PGF) Antibody

20-abx306392 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

20-abx174070 Abbexa
  • 844.80 EUR
  • 427.20 EUR
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx174071 Abbexa
  • 1011.60 EUR
  • 526.80 EUR
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx178023 Abbexa
  • 1362.00 EUR
  • 661.20 EUR
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx178024 Abbexa
  • 1545.60 EUR
  • 744.00 EUR
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx102283 Abbexa
  • 360.00 EUR
  • 159.60 EUR
  • 961.20 EUR
  • 510.00 EUR
  • 309.60 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

20-abx102284 Abbexa
  • 376.80 EUR
  • 159.60 EUR
  • 1028.40 EUR
  • 526.80 EUR
  • 326.40 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

20-abx102285 Abbexa
  • 510.00 EUR
  • 159.60 EUR
  • 1412.40 EUR
  • 693.60 EUR
  • 393.60 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

abx433146-200ul Abbexa 200 ul 460.8 EUR

Placenta Growth Factor (PLGF) Antibody

20-abx142140 Abbexa
  • 444.00 EUR
  • 727.20 EUR
  • 376.80 EUR
  • 100 ul
  • 200 ul
  • 50 ul

Placenta Growth Factor (PGF) Antibody (HRP)

20-abx306393 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody

20-abx313859 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody

abx236511-100ug Abbexa 100 ug 577.2 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx102925 Abbexa
  • 543.60 EUR
  • 159.60 EUR
  • 1579.20 EUR
  • 744.00 EUR
  • 410.40 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx132127 Abbexa
  • 427.20 EUR
  • 1111.20 EUR
  • 560.40 EUR
  • 184.80 EUR
  • 326.40 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx307413 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PGF) Antibody (FITC)

20-abx306394 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

PLGF Antibody / PGF / Placenta Growth Factor

V2223-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V2223-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V2223SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

RQ4653 NSJ Bioreagents 100ug 356.15 EUR
Description: Placental growth factor (PGF, also known as PLGF) codes for an angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). It is a glycosylated dimeric secreted protein able to stimulate endothelial cell growth in vitro. PGF is located on chromosome 14 and has been conserved in evolution. It belongs to the family of vascular endothelial growth factors (VEGFs) and binds to the flt-1 VEGF receptor. PLGF-2, which is a PLGF isoform, binds neuropilin-1 and 2 in a heparin-dependent manner. PGF regulates inter- and intra molecular cross talk between the VEGF RTKs Flt1 and Flk1 and stimulates the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Moreover, it plays an important role in pathological angiogenic events and with exerting its biological activities through binding to VEGFR1.

Plgf Antibody / Pgf / Placenta growth factor

R32889 NSJ Bioreagents 100 ug 356.15 EUR
Description: Placenta growth factor (PGF, also known as PLGF) codes for an angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). It is a glycosylated dimeric secreted protein able to stimulate endothelial cell growth in vitro. PGF is located on chromosome 14 and has been conserved in evolution. It belongs to the family of vascular endothelial growth factors (VEGFs) and binds to the flt-1 VEGF receptor. PLGF-2, which is a PLGF isoform, binds neuropilin-1 and 2 in a heparin-dependent manner. PGF regulates inter- and intra molecular cross talk between the VEGF RTKs Flt1 and Flk1 and stimulates the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Moreover, it plays an important role in pathological angiogenic events and with exerting its biological activities through binding to VEGFR1.

PLGF Antibody / PGF / Placenta Growth Factor

V3161-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V3161-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V3161SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

Placenta-Specific Protein 1 (PLAC1) Antibody

abx030937-400ul Abbexa 400 ul 627.6 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

abx030937-80l Abbexa 80 µl 343.2 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

abx036602-100ug Abbexa 100 ug 469.2 EUR

Placenta-Specific Protein 4 (PLAC4) Antibody

abx028782-400ul Abbexa 400 ul 627.6 EUR

Placenta-Specific Protein 4 (PLAC4) Antibody

abx028782-80l Abbexa 80 µl 343.2 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

20-abx310990 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

PLAC9 Antibody / Placenta-specific protein 9

RQ4388 NSJ Bioreagents 100 ug 356.15 EUR
Description: By microarray assay to search for mouse genes enriched in placenta, Plac9 was identified as a placenta-enriched gene expressed in mouse 16-cell morula cDNA. By database analysis, human PLAC9, which encodes a deduced 97-amino acid protein, was identified. The deduced 108-amino acid mouse protein has a predicted signal peptide, a coiled-coil domain, and shares 73% identity with human PLAC9. Northern blot analysis of mouse placenta and embryo RNA at 12.5 and 18.5 days postcoitum (dpc) detected predominant expression in placenta.

Placenta Growth Factor (PLGF) Antibody (FITC)

20-abx271259 Abbexa
  • 393.60 EUR
  • 260.40 EUR
  • 1111.20 EUR
  • 560.40 EUR
  • 343.20 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody

20-abx249451 Abbexa
  • 376.80 EUR
  • 117.60 EUR
  • 477.60 EUR
  • 594.00 EUR
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Insulin-Like 4 (Placenta) (INSL4) Antibody

20-abx324864 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody

abx036652-100ug Abbexa 100 ug 469.2 EUR

Insulin-Like 4 (Placenta) (INSL4) Antibody

20-abx307015 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PGF) Antibody (Biotin)

20-abx306395 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody (Biotin)

20-abx271525 Abbexa
  • 393.60 EUR
  • 260.40 EUR
  • 1045.20 EUR
  • 543.60 EUR
  • 326.40 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody (HRP)

20-abx313860 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody (HRP)

20-abx307414 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody (FITC)

20-abx313861 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody (FITC)

20-abx307415 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Specific Protein 1 (PLAC1) Antibody (HRP)

20-abx310991 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody (HRP)

20-abx307016 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PLGF) Polyclonal Antibody

CAU28579-100ul Biomatik Corporation 100ul 229.4 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody

CAU28579-200ul Biomatik Corporation 200ul 287.3 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody

CAU28580-100ul Biomatik Corporation 100ul 179 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody

CAU28580-200ul Biomatik Corporation 200ul 219 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody

CAU28581-100ul Biomatik Corporation 100ul 179 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody

CAU28581-200ul Biomatik Corporation 200ul 219 EUR

Placenta Specific Protein 8 (PLAC8) Antibody (Biotin)

20-abx313862 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody (Biotin)

20-abx272460 Abbexa
  • 577.20 EUR
  • 292.80 EUR
  • 1713.60 EUR
  • 811.20 EUR
  • 427.20 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody (Biotin)

20-abx307416 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Specific Protein 1 (PLAC1) Antibody (FITC)

20-abx310992 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody (FITC)

20-abx307017 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Rat Placenta PrimaCell: Normal Placenta Amniotic Cells

2-82579 CHI Scientific 1 Kit Ask for price

Placenta-Specific 1-Like Protein (PLAC1L) Antibody

abx236510-100ug Abbexa 100 ug 661.2 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody (Biotin)

20-abx310993 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Insulin-Like 4 (Placenta) (INSL4) Antibody (Biotin)

20-abx307018 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Human Placenta PrimaCell: Normal Placenta Amniotic Cells

2-96098 CHI Scientific 1 Kit Ask for price

Placenta Lysate

1309 ProSci 0.1 mg 229.2 EUR
Description: Placenta tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Placenta Lysate

21-393 ProSci 0.1 mg 500.1 EUR
Description: Mouse placenta tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The mouse placenta tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the placenta tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The placenta tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Placenta Lysate

21-469 ProSci 0.1 mg 342.6 EUR
Description: Rat placenta tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rat placenta tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the placenta tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The placenta tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Placenta Specific Protein 9 (PLAC9) Polyclonal Antibody

CAU31919-100ul Biomatik Corporation 100ul 259.2 EUR

Placenta Specific Protein 9 (PLAC9) Polyclonal Antibody

CAU31919-200ul Biomatik Corporation 200ul 324.2 EUR

Placenta Specific Protein 9 (PLAC9) Monoclonal Antibody

CAU29479-100ul Biomatik Corporation 100ul 272.6 EUR

Placenta Specific Protein 9 (PLAC9) Monoclonal Antibody

CAU29479-200ul Biomatik Corporation 200ul 341 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody (Rat)

4-PAA114Ra01 Cloud-Clone
  • 291.60 EUR
  • 2948.40 EUR
  • 735.60 EUR
  • 366.00 EUR
  • 254.40 EUR
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Placenta Growth Factor (PLGF)

Human Placenta-specific Gene 8 Protein (PLAC8) Antibody

33024-05111 AssayPro 150 ug 313.2 EUR

Placenta Growth Factor (PLGF) Polyclonal Antibody (Human)

4-PAA114Hu01 Cloud-Clone
  • 236.40 EUR
  • 2077.20 EUR
  • 537.60 EUR
  • 286.80 EUR
  • 231.60 EUR
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Placenta Growth Factor (PLGF)